Inspectors found ICU Medical made multiple changes to infusion pumps without submitting premarket notifications.

The Food and Drug Administration sent a warning letter in early April to ICU Medical, alleging the company failed to submit premarket notifications for changes to infusion pumps. FDA inspectors ...

Globus Medical GMED has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments, the table ...

Wall Street expects a year-over-year increase in earnings on higher revenues when Globus Medical (GMED) reports results for the quarter ended March 2025. While this widely-known consensus outlook ...

AUDUBON, Pa., April 17, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the first quarter ended March ...

AUDUBON, Pa., April 17, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the first quarter ended ...

As you can see from the chart above the percentage of shares that are sold short for Globus Medical has grown since its last report. This does not mean that the stock is going to fall in the near ...

In a report released today, Ryan Zimmerman from BTIG maintained a Buy rating on Globus Medical (GMED – Research Report), with a price target of $88.00. The company’s shares closed last Friday ...

On Thursday, JMP analysts maintained their Market Perform rating for Globus Medical (NYSE:GMED) stock, currently trading at $74.28 with a market capitalization of $10.22 billion. The analysts ...